Captopril

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9G64RSX1XD. European Medicines Agency schedules Captopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06081MIG. Captopril generally arises in the molecular formula C9H15NO3S. The term CAPTOPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) CAPTOPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule captopril under HS 29339990 and SITC 51577. As of Q4 2014, CAPTOPRIL remains the US FDA Preferred Term for this commodity. Captopril bears US NLM identifiers UMLS ID C0006938 and NCI Concept Code C340. SMILES: SCC(C(=O)N1C(CCC1)C(=O)O)C.